Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatmentDistinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple SclerosisOcrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosisBrain-homing CD4+ T cells display glucocorticoid-resistant features in MSDisease activity in primary progressive multiple sclerosisReal-world challenges in the diagnosis of primary progressive multiple sclerosis
author
type
label
Katelijn M Blok
firstName
Katelijn M